Key facts
- This page summarizes Manuel A. Marques's Form 4 filing for REPRO MED SYSTEMS INC (KRMD).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Dec 2021, 15:06.
Manuel A. Marques - 15 Dec 2021 Form 4 Insider Report for REPRO MED SYSTEMS INC (KRMD)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- KRMD
- Reported as of
- 15 Dec 2021
- Net transaction value
- +$31,250
- Reporting owner signature
- /s/ Manuel A. Marques
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Manuel A. Marques filed Form 4 for REPRO MED SYSTEMS INC (KRMD) on 16 Dec 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$31,250.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KRMD
transaction
Common Stock
Options Exercise
- Transaction value
- $31,250
- Shares
- +62,500
- Change %
- +16%
- Price
- $0.5000*
- Shares after
- 443,080
- Date
- 15 Dec 2021
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
KRMD
transaction
Derivative
Options to Purchase Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- -62,500
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 62,500
- Date
- 15 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 62,500
- Exercise price
- $0.5000
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents the payment of the exercise price of stock options through the delivery of previously owned shares to the issuer.
Footnote F2
The price is equal to the Fair Market Value of the Common Stock, as defined in the stock option award agreements, and is used to determine the value of the shares delivered to the issuer in payment of the exercise price.
Footnote F3
Options vest in 15,625 increments quarterly.
SEC remarks
The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.